Virtual Reality-Supported Cardiac Rehabilitation: Psychological, Functional, and Physiological Perspectives
Launched by WROCLAW UNIVERSITY OF HEALTH AND SPORT SCIENCES · Mar 19, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how virtual reality (VR) can help people with heart diseases during their recovery process. The study wants to find out if using VR in cardiac rehabilitation can improve not just physical health, but also mental well-being by reducing feelings of depression, stress, and anxiety. Researchers will compare the effects of VR-assisted rehabilitation to traditional methods, focusing on how it affects overall quality of life, physical activity, and functional abilities.
To participate in this study, individuals aged 18 to 45 who have certain heart conditions, like coronary artery disease or hypertension, may be eligible, as long as they are in the second stage of cardiac rehabilitation at an outpatient facility. However, people with severe mental health issues, current psychiatric treatments, or significant sensory or cognitive impairments will not be able to join. If you participate, you can expect to engage in VR activities designed to support your recovery while receiving care and support from healthcare professionals. This trial is still in the planning stage and has not started recruiting participants yet.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • cardiovascular diseases (atherosclerosis, hypertension, coronary artery disease, ischemic heart disease, peripheral artery disease, rheumatic heart disease, deep vein thrombosis, pulmonary embolism, and post-myocardial infraction)
- • the second stage of cardiac rehabilitation conducted in outpatient settings
- Exclusion Criteria:
- • Severe psychiatric disorders (e.g., psychotic symptoms, bipolar disorder)
- • initiation of psychiatric treatment or individual psychological therapy during the study period
- • current use of antidepressant medications
- • cognitive impairments that hinder questionnaire completion, consciousness disorders
- • sensory impairments (e.g., severe visual or auditory deficits) that limit interaction with virtual reality.
About Wroclaw University Of Health And Sport Sciences
Wrocław University of Health and Sport Sciences is a leading academic institution dedicated to advancing research and education in health and sports sciences. With a strong emphasis on innovative clinical trials, the university aims to enhance evidence-based practice and contribute to the understanding of health-related issues. By fostering collaboration among researchers, healthcare professionals, and students, Wrocław University is committed to promoting public health and optimizing athletic performance through rigorous scientific inquiry and community engagement. Its state-of-the-art facilities and interdisciplinary approach enable the development of impactful solutions that address contemporary health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Czestochowa, Upper Silesia, Poland
Czestochowa, Upper Silesia, Poland
Patients applied
Trial Officials
Błażej Cieślik, PhD.
Principal Investigator
Jan Dlugosz University in Czestochowa
Karolina Kowalewska, MSc.
Principal Investigator
Jan Dlugosz University in Czestochowa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported